Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Myomo Inc MYO

Healthcare Medical Devices
Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. It develops and markets the MyoPro product line. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial... see more

Recent & Breaking News (NYSEAM:MYO)

Myomo To Participate in the 35th Annual Roth Conference

Business Wire March 6, 2023

MyoPro Approved in Australia by National Disability Insurance Scheme

Business Wire February 6, 2023

Myomo Appoints Yitzchak Jacobovitz to its Board of Directors

Business Wire January 30, 2023

Myomo Announces Closing of $6.5 Million Upsized Public Offering

Business Wire January 17, 2023

Myomo Announces Pricing of $6.5 Million Upsized Public Offering

Business Wire January 12, 2023

Myomo Announces Initiative to Reduce Cash Burn

Business Wire January 10, 2023

Myomo Provides Update on Progress to Obtain Medicare Part B Reimbursement for MyoPro

Business Wire December 7, 2022

Ruling by German Social Court Supports MyoPro Reimbursement by Nation's Statutory Health Insurance System

Business Wire December 5, 2022

Myomo Reports Third Quarter 2022 Financial Results Featuring Strong Authorizations and Orders and Record Backlog

Business Wire November 10, 2022

Myomo to Report Third Quarter Financial Results on November 10, 2022

Business Wire November 3, 2022

Myomo To Present at the MicroCap Rodeo Presents The Windy City Roundup 2022

Accesswire October 5, 2022

Myomo to Present at the H.C. Wainwright 24th Annual Global Investment Conference

Business Wire September 7, 2022

Myomo Receives Order from the Louis Stokes Cleveland VA Medical Center to Support MyoPro Clinical Trial

Business Wire August 30, 2022

Myomo Reports Second Quarter 2022 Financial Results and Record Number of Patient Pipeline Additions

Business Wire August 3, 2022

Myomo to Report Second Quarter Financial Results on August 3, 2022

Business Wire July 27, 2022

Myomo Announces Second Quarter Preliminary Revenue and Record Pipeline Additions

Business Wire July 7, 2022

Myomo To Present at the Sidoti Summer Small Cap Virtual Investor Conference

Business Wire June 9, 2022

Myomo Reports First Quarter 2022 Financial Results

Business Wire May 11, 2022

Myomo to Report First Quarter Financial Results on May 11, 2022

Business Wire May 4, 2022

Myomo Reports Progress with China Joint Venture, Receives Partial Payment of Technology License Fee

Business Wire April 4, 2022